Effect of desynchronized inputs on compound sensory and muscle action potentials
β Scribed by Dr. Jun Kimura; Yoko Sakimura; Masafumi Machida; Yasunori Fuchigami; Tetsuro Ishida; Detlef Claus; Shigeki Kameyama; Yuji Nakazumi; Jin Wang; Thoru Yamada
- Publisher
- John Wiley and Sons
- Year
- 1988
- Tongue
- English
- Weight
- 606 KB
- Volume
- 11
- Category
- Article
- ISSN
- 0148-639X
No coin nor oath required. For personal study only.
β¦ Synopsis
Stimulation of the second (S,) or third (S, ) digit elicits a median sensory potential at the wrist. Similarly, a shock applied to the median ( S, ) or ulnar (S,) nerve at the wrist evokes a sensory potential of the fourth digit and a muscle potential over the thenar eminence. Hence, a concomitant application of S, and S2 or S, and S, with varying interstimulus intervals simulates the effect of desynchronized inputs. In 10 hands, a shift in latency on the order of 1 rnsec between S, and S, or S, and S, caused a major reduction in sensory potential by as much as 30-40Β°/o but little change in muscle action potential. A latency difference slightly less than one-half the total duration of unit discharge maximized the phase cancellation between the two components and consequently the loss of area under the waveform.
π SIMILAR VOLUMES
## Abstract ## Introduction: The compound muscle action potential (CMAP) following ulnar nerve stimulation receives a considerable contribution from farβfield potentials (FFPs), although their origin is not entirely clear. We investigated this issue using voluntary contractions. ## Methods: In 7
## Abstract Compound muscle action potential (CMAP) onset latency is interpreted to reflect the arrival time at the muscle of impulses in the fastestβconducting motor nerve fiber. However, we have observed that the position of the reference or indifferent electrode (E2) affects CMAP onset latency.
To develop a symptomatic treatment for amyotrophic lateral sclerosis, we compared the effects of ultrahigh-dose and low-dose (25 and 0.5 mg/day, intramuscularly, for 14 days) methylcobalamin on averaged compound muscle action potential amplitudes (CMAPs) in a double-blind trial. No significant chang